⌘K

Login Start Free

Home/Filings/4/0001209191-22-016205

4//SEC Filing

CHEN JIN-LONG 4

Accession 0001209191-22-016205

CIK 0001426332other

View on SEC.gov Company Profile

Filed

Mar 3, 7:00 PM ET

Accepted

Mar 4, 4:09 PM ET

Size

5.4 KB

Accession

0001209191-22-016205

Insider Transaction Report

Form 4

Period: 2022-03-03

NGM BIOPHARMACEUTICALS INCNGM

DirectorChief Scientific Officer

Transactions

Award
Stock Option (Right to Buy)
2022-03-03+175,000→ 175,000 total
Exercise: $15.20Exp: 2032-03-02→ Common Stock (175,000 underlying)

Footnotes (1)

[F1]The shares subject to the stock option vest over a four-year period commencing January 1, 2022, with 1/48th of the shares vesting on a monthly basis.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

NGM BIOPHARMACEUTICALS INC

CIK 0001426332

Entity typeother

Related Parties

1

filerCIK 0001642996

Filing Metadata

Form type: 4
Filed: Mar 3, 7:00 PM ET
Accepted: Mar 4, 4:09 PM ET
Size: 5.4 KB

View on SEC.gov